Unity Biotechnology, Inc.
-
Ticker
UBX
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in South San Francisco, California
Unity Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases.
Unity Biotechnology, Inc.
Most Recent Annual Report
MOST RECENT
2019 Annual Report and Form 10K
Report Locked. Unity Biotechnology, Inc. has reached its limit for free report views.
Older/Archived Annual Reports